Partner Headlines - CGEN

  1. Benzinga's Top #PreMarket Losers

    Benzinga
  2. Morning Market Gainers

    Benzinga
  3. Morning-Market Movers Led By Aeropostale, Coca-Cola & Coupons.Com

    Benzinga
  4. Morning Market Gainers

    Benzinga
  5. Monday Morning Movers: Achillion Up, Regulus Down Following Drug ...

    Benzinga
  6. Benzinga's Top #PreMarket Gainers

    Benzinga
  7. Stocks Hitting 52-Week Lows

    Benzinga
  8. Compugen Discloses Successful Validation Results For Novel B7/CD28–like ...

    Benzinga
  9. Morning Market Movers

    Benzinga
  10. US Stock Futures Edge Lower Ahead Of ADP Report

    Benzinga
  11. Compugen Reports Results Further Confirming CGEN-15049 as 'Promising' ...

    Benzinga
  12. Benzinga's Top #PreMarket Losers

    Benzinga
  13. Benzinga's Top Initiations

    Benzinga
  14. Morning Market Movers

    Benzinga
  15. US Stock Futures Decline Ahead Of Economic Data

    Benzinga
  16. Compugen Reports Positive Experimental Results for Novel Checkpoint ...

    Benzinga
  17. Morning Market Movers

    Benzinga
  18. Benzinga's Top #PreMarket Gainers

    Benzinga
  19. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE ...

    Benzinga
  20. Compugen Ltd. Prices 6M Share Public Offering at $10.50 per Share

    Benzinga
  21. Benzinga's Top #PreMarket Losers

    Benzinga
  22. Compugen to Significantly Expand Immuno-Oncology Activitiesin ...

    Benzinga
  23. Compugen, Bayer sign accord

    IBD
  24. Market Wrap For Monday, August 5: Stocks Close Mixed; Nasdaq ...

    Benzinga
  25. Morning Market Movers

    Benzinga
  26. Compugen Shares Rocket Higher as Co. Announces Collaboration, ...

    Benzinga
  27. Compugen Announces Discovery of Two Novel Immune Checkpoint Targets ...

    Benzinga
  28. Compugen Drug Candidate Demonstrates Attenuation of Autoimmunity ...

    Benzinga
  29. Towers Watson &, Ubiquiti Networks Among Stocks hitting 52-Week ...

    FoxBusiness
  30. Compugen Says Cancer Target Results Demonstrate Significant Potential ...

    Benzinga
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!